The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR)
is increasingly recognized as an independent clinical entity. Hence, interventional TR …

Tricuspid regurgitation (TR) is a highly prevalent and heterogeneous valvular disease,
independently associated with excess mortality and high morbidity in all clinical contexts. TR …

Acute heart failure (AHF) represents a broad spectrum of disease states, resulting from the
interaction between an acute precipitant and a patient's underlying cardiac substrate and …

Transcatheter tricuspid valve interventions (TTVI) are emerging as alternatives to surgery in
high-risk patients with isolated or concomitant tricuspid regurgitation. The development of …

Background Transcatheter tricuspid valve intervention became an option for pacemaker
lead-associated tricuspid regurgitation. This study investigated the progression of tricuspid …

Highlights•Severe TR is associated with progressive RV volume overload and RV-PA
uncoupling.•TV morphological and mechanistic assessment is critical to device success.•RV …

Tricuspid regurgitation is a frequent and serious condition but tricuspid valve (TV) surgery,
that may be a valve replacement when a repair is not feasible, is rarely performed. Recent …

New-onset or worsening tricuspid regurgitation (TR) is a well-established complication
encountered after cardiac implantable electronic devices (CIEDs). However, there are …

Background Tricuspid regurgitation is associated with significant morbidity and mortality, but
with limited treatment options. The objective of this study is to compare the demographic …

Transcatheter tricuspid valve intervention (TTVI) has recently emerged as an alternative for
the treatment of severe tricuspid regurgitation (TR). Multiple percutaneous devices have …